A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma. [electronic resource]
Producer: 20190429Description: 383-388 p. digitalISSN:- 1095-8673
- Adrenal Cortex Neoplasms -- mortality
- Adrenocortical Carcinoma -- mortality
- Adult
- Antineoplastic Agents -- administration & dosage
- Cisplatin -- administration & dosage
- Cytoreduction Surgical Procedures -- adverse effects
- Female
- Follow-Up Studies
- Humans
- Hyperthermia, Induced -- adverse effects
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- mortality
- Patient Selection
- Peritoneal Neoplasms -- mortality
- Prognosis
- Progression-Free Survival
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.